20.96

3.71% 0.75

Pre-market: 21.18 0.22 +1.05%

Staar Surgical Co (STAA)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Staar Surgical Co stock is traded at $20.96, with a volume of 620.19K. It is up +3.71% in the last 24 hours and up +13.54% over the past month. Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

Previous Close:

$20.21

Open:

$20.21

24h Volume:

620.19K

Relative Volume:

0.43

Market Cap:

$1.04B

Revenue:

$239.44M

Net Income/Loss:

$-80.45M

P/E Ratio:

-12.86

EPS:

-1.6303

Net Cash Flow:

$-40.05M

1W Performance:

+14.29%

1M Performance:

+13.54%

6M Performance:

-21.88%

1Y Performance:

+31.66%

1-Day Range:

$20.21

$21.04

1-Week Range:

$18.38

$21.04

52-Week Range:

$14.69

$30.81

Staar Surgical Co Stock (STAA) Company Profile

Name

Staar Surgical Co

Sector

Healthcare (1116)

Industry

Medical Instruments & Supplies (58)

Phone

(626) 303-7902

Address

1911 WALKER AVE, MONROVIA, CA

Employee

957

Twitter

@visianicl

Next Earnings Date

2026-03-03

Latest SEC Filings

STAA's Discussions on Twitter

Compare STAA vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STAA Staar Surgical Co	20.96	1.04B	239.44M	-80.45M	-40.05M	-1.6303
ISRG Intuitive Surgical Inc	452.58	160.74B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	155.32	44.18B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	74.63	36.34B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	43.88	35.62B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	224.93	32.77B	5.40B	1.49B	1.78B	10.12

Staar Surgical Co Stock (STAA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-03-26	Initiated	Wedbush	Neutral
Jan-16-26	Resumed	Morgan Stanley	Underweight
Apr-21-25	Initiated	Wells Fargo	Equal Weight
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy
Mar-11-24	Upgrade	Stifel	Hold → Buy
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy
Dec-08-22	Initiated	Stifel	Hold
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight
Oct-13-22	Initiated	Mizuho	Buy
Apr-08-22	Initiated	Needham	Buy
Mar-28-22	Upgrade	The Benchmark Company	Hold → Buy
Mar-18-22	Upgrade	BTIG Research	Neutral → Buy
Jul-09-21	Initiated	Oppenheimer	Perform
Jan-19-21	Downgrade	The Benchmark Company	Buy → Hold
Oct-26-20	Downgrade	Sidoti	Buy → Neutral
Aug-31-20	Upgrade	Sidoti	Neutral → Buy
Aug-06-20	Reiterated	The Benchmark Company	Buy
Jul-06-20	Downgrade	Sidoti	Buy → Neutral
Jun-24-20	Downgrade	BTIG Research	Buy → Neutral
Jun-15-20	Initiated	Jefferies	Buy
Dec-04-19	Initiated	BTIG Research	Buy
Sep-24-18	Reiterated	The Benchmark Company	Buy
Aug-06-18	Resumed	The Benchmark Company	Buy
Nov-20-17	Reiterated	The Benchmark Company	Buy
Aug-14-17	Reiterated	The Benchmark Company	Buy
Mar-03-17	Reiterated	The Benchmark Company	Buy
May-18-16	Upgrade	The Benchmark Company	Hold → Buy
Sep-10-13	Resumed	The Benchmark Company	Buy
Feb-28-13	Reiterated	The Benchmark Company	Buy
Nov-01-12	Downgrade	Canaccord Genuity	Buy → Hold
Mar-02-12	Initiated	Northland Securities	Outperform
Oct-25-11	Reiterated	The Benchmark Company	Buy
Oct-12-10	Initiated	Morgan Joseph	Buy
May-11-10	Initiated	Benchmark	Buy

View All

Staar Surgical Co Stock (STAA) Latest News

Apr 06, 2026

Surging earnings estimates signal upside for Staar Surgical (STAA) stock - MSN

Apr 06, 2026

Apr 04, 2026

STAA Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai

Apr 04, 2026

Stifel cuts Staar Surgical stock price target on weak Q4 results - Investing.com

Apr 03, 2026

Apr 02, 2026